| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Biotech Target N V is a 10% Owner at MACROGENICS INC with holdings across 3 companies. Recent SEC Form 4 filings include 13 buys and 0 sells.
Estimated insider holdings value: $72.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 | MGNX MacRogenics Inc | 10% Owner | Buy | 600,000 | $20.61 | $12,363,480.00 | +4.6% | -19.2% | -83.2% | |
| Jun 21, 2021 | MGNX MacRogenics Inc | 10% Owner | Buy | 75,000 | $21.74 | $1,630,170.00 | +1.2% | -4.2% | -87.0% | |
| Jun 16, 2021 | MGNX MacRogenics Inc | 10% Owner | Buy | 175,000 | $20.82 | $3,644,005.00 | +1.4% | +30.4% | -89.2% | |
| May 24, 2021 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 100,000 | $20.22 | $2,021,620.00 | +2.3% | -31.9% | -71.4% | |
| May 19, 2021 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 200,000 | $20.37 | $4,073,960.00 | +4.8% | -30.3% | -69.8% | |
| May 6, 2021 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 230,000 | $20.21 | $4,648,482.00 | +2.9% | -32.7% | -73.5% | |
| Nov 3, 2020 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 200,000 | $25.31 | $5,062,120.00 | +5.3% | - | - | |
| Jan 23, 2020 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 20,000 | $52.12 | $1,042,398.00 | +0.5% | - | - | |
| Nov 6, 2019 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 75,000 | $37.30 | $2,797,560.00 | +2.1% | - | - | |
| Sep 4, 2019 | ESPR Esperion Therapeutics, Inc. | 10% Owner | Buy | 80,000 | $33.78 | $2,702,208.00 | +2.2% | - | - |